Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress - PubMed (original) (raw)
Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress
Kusum K Kharbanda et al. Biomolecules. 2018.
Abstract
The symposium, "Role of Nutrition in Alcoholic Liver Disease", was held at the European Society for Biomedical Research on Alcoholism Congress on 9 October 2017 in Crete, Greece. The goal of the symposium was to highlight recent advances and developments in the field of alcohol and nutrition. The symposium was focused on experimental and clinical aspects in relation to the role of different types of dietary nutrients and malnutrition in the pathogenesis of alcoholic liver disease (ALD). The following is a summary of key research presented at this session. The speakers discussed the role of dietary fats and carbohydrates in the development and progression of alcohol-induced multi-organ pathology in animal models of ALD, analyzed novel nutrition-related therapeutics (specifically, betaine and zinc) in the treatment of ALD, and addressed clinical relevance of malnutrition and nutrition support in ALD. This summary of the symposium will benefit junior and senior faculty currently investigating alcohol-induced organ pathology as well as undergraduate, graduate, and post-graduate students and fellows.
Keywords: alcoholic liver disease; betaine; carbohydrates; fat; malnutrition; nutrition; nutritional support in ALD; zinc.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1
Elevated levels of polyunsaturated fatty acid (PUFA) metabolites in liver injury caused by acute-on-chronic ethanol administration. (A) Plasma alanine aminotransferase (ALT) levels were significantly higher in mice fed ethanol and unsaturated fat compared to ethanol and dietary saturated fat; (B) oxidized metabolites of linoleic acid; (C) oxidized metabolites of arachidonic acid. SF: saturated fat; EtOH: ethanol-fed; USF: unsaturated fat; HODE: hydroxyoctadecadienoic acids; HETE: hydroxyeicosatetraenoic acids; * p < 0.05.
Figure 2
Effects of gestational second-hand smoke (SHS) on body weight and liver pathology in male C57BL/6 mice fed chow or pair-fed Lieber DeCarli liquid diets at up to 28% ethanol calories for 16 weeks beginning on post-natal day 65. PF: pair-fed dextrose/maltodextran. a < b < c, significantly different at p < 0.05.
Figure 3
Time-course handgrip assessment in patient with moderate alcoholic hepatitis. (A) Correlation analysis between hand grip response and Model for End-Stage Liver Disease (MELD) score; (B) hand grip dynamometry.
References
- Purohit V., Abdelmalek M.F., Barve S., Benevenga N.J., Halsted C.H., Kaplowitz N., Kharbanda K.K., Liu Q.Y., Lu S.C., McClain C.J., et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium. Am. J. Clin. Nutr. 2007;86:14–24. doi: 10.1093/ajcn/86.1.14. -DOI -PubMed
- Kharbanda K.K., Mailliard M.E., Baldwin C.R., Beckenhauer H.C., Sorrell M.F., Tuma D.J. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J. Hepatol. 2007;46:314–321. doi: 10.1016/j.jhep.2006.08.024. -DOI -PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA024102/AA/NIAAA NIH HHS/United States
- U01 AA021893/AA/NIAAA NIH HHS/United States
- U01 AA021901/AA/NIAAA NIH HHS/United States
- P20 GM113226/GM/NIGMS NIH HHS/United States
- I01 BX001155/BX/BLRD VA/United States
- P50 AA024337/AA/NIAAA NIH HHS/United States
- R37 AA009300/AA/NIAAA NIH HHS/United States
- R01 AA023681/AA/NIAAA NIH HHS/United States
- P30 GM106392/GM/NIGMS NIH HHS/United States
- U01 AA022489/AA/NIAAA NIH HHS/United States
- I01 BX000350/BX/BLRD VA/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical